Clinical trial
5-Flourouracil Preceded by Irinotecan In Patients With Advanced Solid Tumors: A Pilot Study
NCT00024141 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 5-Flourouracil Preceded by Irinotecan In Patients With Advanced Solid Tumors: A Pilot Study
- Lead sponsor
- Roswell Park Cancer Institute
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2001
- Completion date
- January 31, 2003
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
unspecified adult solid tumor, protocol specific